by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: ASCO Daily News Dr. John Sweetenham shares highlights from Day 5 of the 2025 ASCO Annual Meeting, including data from large trials in advanced malignant melanoma and mCSPC plus a new approach to first-line treatment for patients with multiple myeloma who are...
by MM360 Staff | Jun 3, 2025 | Myeloma News
Source: Pharmacy Times articles Amanda Gronniger, PharmD, CPh, BCCP discusses practical strategies pharmacists can use to improve cholesterol management, from lifestyle counseling to emerging therapies. Read More
by MM360 Staff | Jun 3, 2025 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, reinforcing it as a new SOC. Read More
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer. Read More
